A drug Merck is developing for chronic cough failed to win over a panel of advisors to the Food and Drug Administration on Friday, making approval unlikely. The FDA’s Pulmonary-allergy Drugs Advisory ...
Verywell Health on MSN

Best cough medicine: A complete guide

Medically reviewed by Alex Yampolsky, PharmD Key Takeaways The type of cough medicine you need depends on whether your cough ...
The over-the-counter drug industry is rolling out a campaign to raise awareness about the abuse of cough medicines in an effort to head off harsh restrictions on the sales of the widely used products.
Brazil suspends clobutinol cough syrup after detecting a risk of arrhythmias and serious heart rhythm disturbances.
(Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish ...
This cough, cold and flu season, and later the allergy season, will be different from previous seasons. As the tripledemic of viral infections, Respiratory Syncytial Virus (RSV), influenza and ...
Pharma giant GlaxoSmithKline on Tuesday announced a deal to buy Canadian biotech Bellus Health for $2 billion, betting big on the firm’s cough medicine as it moves to shore up its slender drug ...
MarketBeat's Top 5 Rated Small-Cap Stocks Trevi Therapeutics (NASDAQ:TRVI) outlined plans to advance Haduvio, its ...
China-based company Xiamen Kang Zhongyuan Biotechnology Co., Ltd has issued a recall for multiple cough drop products, according to the Food and Drug Administration.
The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol. Reading time 3 minutes An important clinical trial for Parkinson’s disease ...
Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...
Multiple popular cough drops were recalled nationwide due to possible quality concerns after an FDA inspection. Is your brand ...